Reports for Auregen BioTherapeutics SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Shareholder Information
Find out which national and international companies the stock corporation you are interested in also holds shares in.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Auregen BioTherapeutics SA
- Auregen BioTherapeutics SA has its legal headquarters in Genève and is active. It operates in the sector «Research and development».
- The management has 4 active persons registered.
- All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 06.02.2025.
- The reported UID is CHE-405.423.634.
- 2 various trademarks or applications have been registered by the company Auregen BioTherapeutics SA in the IPI.
- Companies with the same address as Auregen BioTherapeutics SA: B-FLEXION Advisors (Switzerland) SA, B-FLEXION Group Holdings SA, B-FLEXION Holdings (Switzerland) SA.
Management (4)
newest board members
Fereydoun Firouz,
Jason Meyenburg,
Frédéric Yves Boder,
Marcy Zenobi-Wong
newest authorized signatories
Fereydoun Firouz,
Jason Meyenburg,
Frédéric Yves Boder,
Marcy Zenobi-Wong
Commercial register information
Entry in the commercial register
14.12.2016
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.3.573.016-9
UID/VAT
CHE-405.423.634
Sector
Research and development
Purpose (Original language)
Recherche, développement, mise à l'essai, production et marketing de produits dans le domaine des sciences de la vie (cf. statuts pour but complet).
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| PricewaterhouseCoopers SA | Genève | 19.12.2016 | ||
Other company names
Es sind keine früheren oder übersetzten Firmannamen vorhanden.
Would you like to update the company name? Click here.Branches (1)
Ownership structure
Holdings
Trademarks
| Trademark | Registration date | Status | Number |
|---|---|---|---|
| Auregen BioTherapeutics | 10.11.2016 | active | 62631/2016 |
| Auregen BioTherapeutics | 10.11.2016 | active | 62631/2016 |
Newest SOGC notifications: Auregen BioTherapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006250034, Commercial Registry Office Geneva, (660)
Auregen BioTherapeutics SA, à Genève, CHE-405.423.634 (FOSC du 28.03.2024, p. 0/1005997556). Wilson Donald Travis, De Luca Giampiero, Seltzer Stacey, Vigilante Michael et Kesti Matti Jaakko Johannes ne sont plus administrateurs;
leurs pouvoirs sont radiés. Firouz Fereydoun, de Genève, à Bethlehem, USA, est membre président du conseil d'administration avec signature collective à deux.
Publication number: HR02-1005997556, Commercial Registry Office Geneva, (660)
Auregen BioTherapeutics SA, à Genève, CHE-405.423.634 (FOSC du 08.08.2023, p. 0/1005812420). Lacour Gilles n'est plus administrateur;
ses pouvoirs sont radiés.
Publication number: HR02-1005812420, Commercial Registry Office Geneva, (660)
Auregen BioTherapeutics SA, à Genève, CHE-405.423.634 (FOSC du 10.07.2023, p. 0/1005791738). Radiation de la mention de l'existence d'une succursale à Zurich (CHE-309.180.921).
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.